Platelets and cancer metastasis: a causal relationship?

Area of Science:

• Oncology
• Hematology
• Cell Biology

Background:

• Cancer metastasis is a complex process involving tumor cell interactions with host cells.
• Circulating tumor cells frequently associate with platelets, suggesting a role in metastasis.
• Tumor cell-platelet interactions (TCIPA) are increasingly recognized as key drivers of hematogenous metastasis.

Purpose of the Study:

• To explore the significant contribution of tumor cell-platelet interactions (TCIPA) to cancer metastasis.
• To elucidate the mechanisms by which platelets promote cancer cell survival, proliferation, and dissemination.
• To highlight the potential of targeting TCIPA as a therapeutic strategy against metastasis.

Main Methods:

• Review of morphological studies documenting tumor cell-platelet associations.
• Analysis of clinical data linking thrombocytosis in cancer patients to thromboembolic disorders.
• Examination of pharmacological and experimental evidence demonstrating the impact of anti-platelet agents on metastasis.

Main Results:

• Platelets stabilize circulating tumor cells, promote their proliferation, and enhance extravasation.
• Key mediators of TCIPA include membrane-bound molecules like alpha IIb beta 3 integrins and soluble products such as 12(S)-HETE.
• Interference with TCIPA steps diminishes platelet aggregation and blocks experimental metastasis.

Conclusions:

• Tumor cell-platelet interactions are critical for multiple steps of the metastatic cascade.
• Platelets provide a supportive microenvironment for tumor cells during hematogenous spread.
• Targeting TCIPA represents a promising avenue for developing novel anti-metastatic therapies.